DOACs for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
Circulation 2023 Nov 12;[EPub Ahead of Print], WF McIntyre, AP Benz, N Becher, JS Healey, CB Granger, L Rivard, AJ Camm, A Goette, A Zapf, M Alings, SJ Connolly, P Kirchhof, RD LopesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.